An army of "citizen developers" armed with nifty low-code/no-code software is helping companies accomplish major changes despite a shortage of programmers. Read More...
Benzinga
Why Codexis Shares Are Slumping Today
Codexis Inc (NASDAQ: CDXS) expects Q2 sales of approximately $38 million and FY22 sales of 135 million to $141 million, below the propr expectation of $152 million – $158 million. FY22 product revenues are expected to be $112 million – $118 million, consistent with prior guidance. However, product revenues from Pfizer Inc (NYSE: PFE) are now expected to be at the low end of previous guidance of $75 million – $80 million, expected to be offset by revenues from other customers. Gross margin on pro
